Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Meredith

Showing results (51-60 of 444) with videos related to

Pageof 45
Sort By:
Advances in Therapy|May 22, 2010
Benefits of nifedipine GITS in stable coronary artery disease: Further analysis of the "ACTION" databasePeter A Meredith, Henry L Elliott
Drugs & Aging|December 31, 1997
Clinical pharmacokinetics of nifedipine. Implications for the care of the elderlyH L Elliott, P A Meredith
Journal of Neurophysiology|September 1, 1986
Visual, auditory, and somatosensory convergence on cells in superior colliculus results in multisensory integrationM A Meredith, B E Stein
Journal of Cardiovascular Pharmacology|January 1, 1994
FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug AdministrationP A Meredith, H L Elliott
Ophthalmology|February 1, 1996
Success with macular hole surgeryN S Melberg, T A Meredith
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1990
Concentration-effect relationships and antihypertensive mechanisms: ketanserin in the treatment of essential hypertensionH L Elliott, P A Meredith
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1990
The visuotopic component of the multisensory map in the deep laminae of the cat superior colliculusM A Meredith, B E Stein
Blood Pressure. Supplement|May 3, 2001
Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. IntroductionP A Meredith, M A Weber
Clinical Pharmacology and Therapeutics|June 1, 1992
An additive or synergistic drug interaction: application of concentration-effect modelingP A Meredith, H L Elliott
British Journal of Clinical Practice. Supplement|May 1, 1994
Therapeutic coverage: reducing the risks of partial complianceP A Meredith, H L Elliott
Pageof 45

Showing results (51-60 of 444) with videos related to

Sort By:
Pageof 45
Advances in Therapy|May 22, 2010
Benefits of nifedipine GITS in stable coronary artery disease: Further analysis of the "ACTION" databasePeter A Meredith, Henry L Elliott
Drugs & Aging|December 31, 1997
Clinical pharmacokinetics of nifedipine. Implications for the care of the elderlyH L Elliott, P A Meredith
Journal of Neurophysiology|September 1, 1986
Visual, auditory, and somatosensory convergence on cells in superior colliculus results in multisensory integrationM A Meredith, B E Stein
Journal of Cardiovascular Pharmacology|January 1, 1994
FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug AdministrationP A Meredith, H L Elliott
Ophthalmology|February 1, 1996
Success with macular hole surgeryN S Melberg, T A Meredith
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1990
Concentration-effect relationships and antihypertensive mechanisms: ketanserin in the treatment of essential hypertensionH L Elliott, P A Meredith
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1990
The visuotopic component of the multisensory map in the deep laminae of the cat superior colliculusM A Meredith, B E Stein
Blood Pressure. Supplement|May 3, 2001
Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. IntroductionP A Meredith, M A Weber
Clinical Pharmacology and Therapeutics|June 1, 1992
An additive or synergistic drug interaction: application of concentration-effect modelingP A Meredith, H L Elliott
British Journal of Clinical Practice. Supplement|May 1, 1994
Therapeutic coverage: reducing the risks of partial complianceP A Meredith, H L Elliott
Pageof 45